期刊文献+

STAT3在小鼠急性病毒性心肌炎发病中的作用研究 被引量:2

Role of STAT3 in the pathogenesis of acute viral myocarditis in mice
下载PDF
导出
摘要 目的:观察STAT3在小鼠急性病毒性心肌炎(Viral myocartditis,VMC)发病中的作用及其可能作用机制。方法:建立急性VMC小鼠模型,将45只小鼠随机分为3组:正常对照组10只、急性VMC组15只,急性VMC+RPM干预鼠20只,分别采用DMEM和STAT3特异性抑剂RPM0.4mg/kg每日腹腔注射,12d后观察小鼠的一般情况及存活率,心肌组织病理变化,心肌组织病毒滴度,ELISA法检测血清IFN-γ和TNF-α含量。结果:与急性VMC鼠相比,急性VMC+RPM干预鼠一般情况明显加重,心肌组织变性坏死及炎性细胞浸润明显加重,并且血清中IFN-γ和TNF-α含量均增加,但心肌组织病毒滴度两组间无明显差异。结论:STAT3活化在病毒性心肌炎小鼠发病中对心肌组织有一定的保护作用,抑制其活化,小鼠对CVB3的易感性明显增加;STAT3活化虽不能干扰心肌组织中病毒复制,但却可通过抑制IFN-γ、TNF-α的过度表达而对心肌组织有一定保护作用。 Objective:To investigate the role of STAT3 in the pathogenesis of acute viral myocarditis(VCM)in mice and its possible mechanism.Methods:Acute VCM mice models were established forty-five mice were randomly divided into blind control group (n=10),virus-infection control group(n=15),RPMintervention group(n=20).In RPM intervention group,RPM was given to mice intraperitoneally once a day with general dosage of 0.4 mg(/kg·d)at 24 hours before infected with coxsackie virus B3,mice of virus-infection control group were given the same volume of Dulbcco's Modifed Eagle Medium and virus.Blind control group was only given the same volume of Dulbcco's Modifed Eagle Medium,but not infected coxsackie virus B3.Twelve days later,the general condition and survival rate of mice were observed and then all experimental mice were sacrificed patholog and detecting CVB3 virus titer in myocardium. And double-sandwich ELISA was used to detect the levels of IFN-γ,and TNF-αin the serum.Results:The pathological changes of myocardium of the mice in RPM intervention displayed more seriously than the mice with acute VMC and both the cytokines expressions in the serum of RPM intervention group were higher than those of the acute VMC group,but there was no significant difference in the virus titer between the two groups.Conclusions:The activation of STAT3 can somehow protect myocardial tissues during the incidence of viral myocarditis in mice to inhibit its activation and improve the sensibility of mice to CVB3,although the activation of STAT3 cannot affect CVB3 virus replication,it can inhibit the over-expression of IFN-γand TNF-αto weaken myocardial damage.
出处 《重庆医科大学学报》 CAS CSCD 北大核心 2010年第7期995-998,共4页 Journal of Chongqing Medical University
基金 重庆市卫生局资助(编号:渝卫科教[07-2-141])
关键词 病毒性心肌炎 信号转导和转导激活子3 雷帕霉素 柯萨奇病毒B3 Viral myocarditis STAT3 Rapamycin Coxsackie virus B3
  • 相关文献

参考文献14

  • 1吴巾红,钟家蓉.信号转导和转录激活子3与病毒性心肌炎的关系[J].临床心血管病杂志,2008,24(1):45-47. 被引量:2
  • 2Reed L J,Muench L H.A simple method of estimating fifty percent and paint[J].AmJ Hygiene,1938,27:493.
  • 3Kawai C.From myocarditis to cardiomyopathy:Mechanisms of inflammation and cell death:Leaming from the past for the future[J].Circulation,1999,99:1091.
  • 4Seko Y.Takahashi N,Yagita H,et al.Expression of cytokine mRNAs in murine hearts with acute myocarditis caused by coxsackie virus B3[J].Pathol,1997,183:105-108.
  • 5Heim A.Canu A,Kirschner P,et al.Synergistic interaction of interferon-beta and interferon-gamma in coxsackie virus B3-infected carrier cultures of human myoca-rdial fibroblasts[J].Infect Dis,1992,166(5):958-965.
  • 6Wada H,Saito K,Kanda T,et al.Tumor necrosis factor-alpha (TNF-α) plays a protective role in acute viral myocarditis in mice:A study using mice lacking TNF-α[J].Circulation.2001,103(5):743-749.
  • 7黄磊,马沛然,汪翼,韩秀珍,王玉林.病毒性心肌炎患儿血清干扰素-γ、肿瘤坏死因子-α的变化及与心肌酶异常的关系[J].实用儿科临床杂志,2004,19(3):191-192. 被引量:16
  • 8Schindlern C,Darnell J E J.Transcriptional responses to polypeptide ligands:the JAK-STAT pathway[J].Annu Rev Biochem,1995,64:621-651.
  • 9Hebenstreit D,Horejs-Hoeck J,Duschl A,et al.JAK/STAT-dependent gene regulation by cytokines[J].Drug News Perspect,2005,18(4):243-249.
  • 10KisselevaT,Bhattacharya S,Braunstein J,et al.Signaling through the JAK/STAT pathway,recent advances and future challenges[J].Gene,2002,285(1-2):1-24.

二级参考文献11

  • 1李双杰,张召才,陈瑞珍,杨英珍,陈灏珠,葛均波.病毒性心脏病细胞凋亡与纤维化的研究[J].临床心血管病杂志,2005,21(1):36-38. 被引量:5
  • 2彭华,刘亚黎,胡晓华,林雯,蒙冰,李玲,陈立敏.黄芪对病毒性心肌炎心肌细胞信号转导及转录活化因子3信号通路的影响[J].实用儿科临床杂志,2005,20(3):218-220. 被引量:32
  • 3KAWAI C. From myocarditis to cardiomyopathy: Mechanism of inflammation and cell death: Learning from the past for the future[J]. Circulation , 1999, 99:1091-1091.
  • 4SCHINDLER C, DARNELL J E. Transcriptional responses to polypeptide ligands:the JAK-STAT pathway[J]. Annu Rev Biochem , 1995,64:621-651.
  • 5IHLE J N. STATs:Signal transducers and activators of transcription[J]. Cell, 1996,84 : 331 - 334.
  • 6HILFIKER-KLEINER D, HILFIKER A, FUCHS M, et al. Signal transducer and activator of transcription 3 is required for myocardial capillary growth, control of interstitial matrix deposition, and heart protection from ischemic iniury[J] .Circ Res, 2004,95 : 187 - 195.
  • 7YASUKAWA H, YAJIMA T, DUPLAIN H, et al. The suppression of cytokine signaling-1 (SOCS1) is a novel therapeutic target for enterovirus-induced cardiac injury [J]. Clin Invest,2003,111:469-478.
  • 8YAJIMA T, YASUKAWA H, JEON E S, et al. Innate defense mechanism against virus infection within the cardiac myocyte requiring gp130-STAT3 signaling[J]. Circulation, 2006,114:2364-2373.
  • 9杨锡强.免疫系统与疾病[J].实用儿科临床杂志,2001,16(2):107-109. 被引量:10
  • 10涂学亮,杨秀珍.心肌5种酶测定的临床价值[J].新乡医学院学报,2002,19(4):268-270. 被引量:22

共引文献16

同被引文献37

  • 1王海燕,张烜.Th17研究进展[J].免疫学杂志,2009,25(5):608-611. 被引量:9
  • 2张松,饶邦复,葛均波.肿瘤坏死因子-α在病毒性心肌炎发病中的作用及意义[J].中国免疫学杂志,2005,21(4):312-314. 被引量:9
  • 3Schultheiss HP,Kuhl U,Cooper LT.The management ofmyoc arditis[J].Eur Heart J,2011,32(21):2616-2625.
  • 4Hirota K,Martin B,Veldhoen M.Development.regulationand functional capacities of Thl7 cells[J].Semin Immu-nopathol,2010,32(1) ;3-16.
  • 5Qpavsky MA,Martino T,Rabinovitch M,et al.EnhancedERK-1/2 activation in mice susceptible to coxsackievirus-induced myocarditis [J].J Clin Invest,2002,109 (12):1561-1569.
  • 6Yuan J.Thl7 cells contribute to viral replication in cox-sackievirus B3-induced acute viral myocarditis [J].J Im-munol,2010,185(7):4004-4010.
  • 7Xie YQ,Chen RZ,Zhang X,et al.The role of Thl7 cellsand regulatory T cells in coxsackievirus B3-induced myo-carditis [J].Virology,2011,421(1):78-84.
  • 8Kondo M.Roles of proinflammatory cytokines and the Fas/Fas ligand interaction in the pathogenesis of inflammatorymyopathies[J].Immunology,2009,128(l):e589-e599.
  • 9Takagi R.Higashi T,Hashimoto K,et al.B cell chemoat-tractant CXCL13 is preferentially expressed by humanThl7 cell clones[J].J Immunol,2008,181(1); 186-189.
  • 10Doreau AS.Interleukin 17 acts in synergy with B cell-acti-vating factor to influence B cell biology and the pathphysiology of systemic lupus erythematosus [J].NatureImmunology,2009,10(7):778-787.

引证文献2

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部